AURA
Aura Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$6.29
+3.11%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-41.6%
Return on equity
-37.6%
Return on assets
-41.6%
Return on invested capital
0.00x
Asset turnover
-$102.3M
Cash from operations
$3.12
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026